Evidence map›Paper›PMID 23531333›Full record

ArticleCritical care (London, England)2013

Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study.

Thomas Rimmelé, Ata Murat Kaynar, Joseph N McLaughlin, Jeffery V Bishop, Morgan V Fedorchak, Anan Chuasuwan, Zhiyong Peng, Kai Singbartl, Daniel R Frederick, Lin Zhu and 4 more

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Removal of activated neutrophils by a polymyxin B-immobilized fiber (PMX) column.The International journal of artificial organs · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Blood purification for sepsis: an overview.Precision clinical medicine · 2021
    Review
  7. Observational
  8. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2020
    Review
  9. Review
  10. Article
  11. Continuous Renal Replacement Therapy: Forty-year Anniversary.The International journal of artificial organs · 2017
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. [Adsorption therapy in sepsis].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2015
    Review
  17. Article
  18. Article
  19. Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2014
    Article
  20. Year in review 2013: Critical Care--sepsis.Critical care (London, England) · 2014
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Thomas Rimmelé
Ata Murat Kaynar
Joseph N McLaughlin
Jeffery V Bishop
Morgan V Fedorchak
Anan Chuasuwan
Zhiyong Peng
Kai Singbartl
Daniel R Frederick
Lin Zhu
Melinda Carter
William J Federspiel
Adriana Zeevi
John A Kellum
University of Pittsburgh · USMcGowan Institute for Regenerative Medicine · US

Funding

Systems Engineering of Pheresis Intervention for SepsisR01HL080926 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELLUM, JOHN A · 2005 to 2009
$6.8M
Neutrophil Collagenase in Sepsis and Ventilator Induced Lung InjuryK08HL086671 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAYNAR, A. MURAT · 2009 to 2013
$603k
NHLBI NIH HHS K08HL086671NHLBI NIH HHS R01HL080926
6 · The paper itself

Abstract

introductionPromising preclinical results have been obtained with blood purification therapies as adjuvant treatment for sepsis. However, the mechanisms by which these therapies exert beneficial effects remain unclear. Some investigators have suggested that removal of activated leukocytes from the circulation might help ameliorate remote organ injury. We designed an extracorporeal hemoadsorption device capable of capturing both cytokines and leukocytes in order to test the hypothesis that leukocyte capture would alter circulating cytokine profiles and influence immunological cell-cell interactions in whole blood taken from patients with sepsis.

methodsWe performed a series of ex vivo studies in 21 patients with septic shock and 12 healthy volunteers. Blood circulated for four hours in closed loops with four specially designed miniaturized extracorporeal blood purification devices including two different hemoadsorption devices and a hemofilter in order to characterize leukocyte capture and to assess the effects of leukocyte removal on inflammation and immune function.

resultsHemoadsorption was selective for removal of activated neutrophils and monocytes. Capture of these cells led to local release of certain cytokines, especially IL-8, and resulted in complex cell-cell interactions involved in cell-mediated immunity. Inhibition of cell adherence reversed the cytokine release and the effects on lymphocyte function.

conclusionsMonocyte and neutrophil capture using a sorbent polymer results in upregulation of IL-8 and modulation of cell-mediated immunity. Further studies are needed to understand better these cellular interactions in order to help design better blood purification therapies.

Indexed as

AdsorptionExtracorporeal CirculationHumansImmunity, CellularLeukocytesSepsis

Identifiers

PMID23531333
PMCPMC3672497
OpenAlexW2169174676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.